Company intelligence / Profile preview

Cell Therapy Biosciences

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Cell Therapy Biosciences is a biotechnology company focused on the development of advanced regenerative medicines and cell-based therapies. The company specializes in the isolation and characterization of mesenchymal stem cells (MSCs) and the development of exosome-based therapeutics for various degenerative conditions. Their research and development efforts target high-need areas such as orthopedic injuries, chronic wound healing, and vascular diseases. By leveraging proprietary processing techniques, Cell Therapy Biosciences aims to provide standardized, high-potency cellular products for clinical applications.

Therapeutic areas: CardiovascularMen's HealthRheumatologyDermatology
Modalities: Cell therapyStem cell therapyExosome-based therapy
Industry: Biotech

Beyond the preview

Go deeper on Cell Therapy Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell Therapy Biosciences.

Explore the full profile